WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry. The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable. “The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release. |
Australian gov't confirms 2nd consecutive budget surplusTerrifying moment motherRossi, Hinestroza help Crew beat Montreal 34 people die in Croatia when car carrying migrants hits a wall as driver attempts to flee police42 rescued and 3 still missing after migrant boat sends distress signal south of GreeceStock market today: World shares are mixed after Wall St hits fresh records on hopes for rate cutsRobert Fico: Slovakian leader is in stable but serious condition, hospital saysMacquarie Bank to go 'fully digital' and ditch cash within daysRobert Fico: Slovakian leader is in stable but serious condition, hospital saysThe three missed opportunities to save Arthur Labinjo